Lesa Sroufe & Co’s Bristol-Myers Squibb BMY Stock Holding History

Lesa Sroufe & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-4,204	Closed	-$281K	–	73
2021 Q2	$281K	Hold	4,204	–	–	0.28%	61
2021 Q1	$265K	Hold	4,204	–	–	0.29%	57
2020 Q4	$261K	Hold	4,204	–	–	0.31%	58
2020 Q3	$253K	Hold	4,204	–	–	0.35%	54
2020 Q2	$247K	Hold	4,204	–	–	0.33%	53
2020 Q1	$234K	Buy	4,204 +300	+8%	+$18.3K	0.32%	52
2019 Q4	$251K	Buy	+3,904	New	+$224K	0.24%	55

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Lesa Sroufe & Co's BMY Position: Q3 2021 in Review

Lesa Sroufe & Co sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 4,204 shares — an estimated $281K sold.

Lesa Sroufe & Co first reported a position in BMY in Q4 2019 and held it in 7 quarters. The position peaked at $281K in Q2 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

Lesa Sroufe & Co reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
Lesa Sroufe & Co sold 4,204 Bristol-Myers Squibb shares in Q3 2021, an estimated $281K.
Lesa Sroufe & Co first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 7 quarters.
Lesa Sroufe & Co's Bristol-Myers Squibb position peaked at $281K in Q2 2021.
2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on Lesa Sroufe & Co's 13F filing for Q3 2021, filed 1 Nov 2021.